A vaccine Taiwan's National Health Research Institutes (NHRI) is developing for the novel coronavirus disease (COVID-19) will enter human trials as early as this autumn, Vice President Lai Ching-te (賴清德) disclosed Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
U.S. dollar down in Taipei trading
07/01/2025 10:14 AM - Society
Taiwan headline news
07/01/2025 10:10 AM - Culture
When 'Plum Rain' falls: A German novelist's love letter to Taiwan
07/01/2025 09:31 AM - Business
Taiwan shares open higher
07/01/2025 09:14 AM - Business
TISA system launched to strengthen citizen financial planning
06/30/2025 10:28 PM